Novel peptide inhibitors of dipeptidyl peptidase IV (DPP IV) as novel approach for diabetes type 2 and inflammatory bowel diseases treatment

2013/11/N/NZ7/02354

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Voivodeship: łódzkie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Maciej Stanisław Sałaga

Number of co-investigators in the project: 3

Call

PRELUDIUM 6 – announced on 2013-09-16

Amount awarded
135 187 PLN
Project start date
2014-09-22
Project end date
2018-09-21
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Information in the final report

Publication in academic press/journals (2)

  1. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis

    Authors:
    Maciej Sałaga, Agata Binienda, Piotr Drączkowski, Piotr Kosson, Radzisław Kordek, Krzysztof Jóżwiak, Jakub Fichna
    Academic press:
    Peptides (year: 2018, volume: 108, pages: 34-45), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/J.PEPTIDES.2018.08.011 – link to the publication
  2. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration

    Authors:
    Maciej Sałaga, Anna Mokrowiecka, Marta Zielińska, Ewa Małecka-Panas, Radzisław Kordek, Elżbieta Kamysz, Jakub Fichna
    Academic press:
    Journal of Pharmacology and Experimental Therapeutics (year: 2017, volume: 363, pages: 92-103), Publisher: American Society for Pharmacology and Experimental Therapeutics
    Status:
    Published
    DOI:
    10.1124/jpet.117.242586 – link to the publication

Articles in post-conference publications (1)

  1. NEW, PEPTIDE INHIBITOR OF DIPEPTIDYL PEPTIDASE IV, EMDB-1 ATTENUATES COLITIS IN MICE AFTER TOPICAL ADMINISTRATION

    Authors:
    Maciej Salaga, Paula Mosinska, Hubert Zatorski, Marta Zielinska, Jakub Fichna
    Conference:
    24th United European Gastroenterology Week (year: 2016, pages: 100), Publisher: United European Gastroenterology
    Date:
    conference 15-19.10
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski